Also in a small cohort of nine patients suffering from secondary GBM, treatment with 213Bi-[Thi8,Met(O2)11]-substance P was well tolerated and resulted in median overall survival of 18.6 months after conversion of the primary low grade glioma to grade IV GBM.10 Here, TAC1 is linked to central nervous system cancer.